Resistance to phorbol 12-myristate 13-acetate-induced cell growth arrest in an HL60 cell line chronically exposed to a glutathione S-transferase π inhibitor

Biochemical Pharmacology

Volumn 65, Issue 10, 2003, Pages 1611-1622

  Gaté, Laurent ^a   Lunk, Alexandra ^a   Tew, Kenneth D ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Differentiation; Extracellular signal regulated kinase; Glutathione S transferase ; Inhibitor; Phorbol 12 myristate 13 acetate; Resistance

Indexed keywords

3,4 DEPHOSTATIN; ENZYME INHIBITOR; GLUTATHIONE TRANSFERASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; TLK 199; UNCLASSIFIED DRUG; VANADATE SODIUM;

ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL LINE; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLOGY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME MODIFICATION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

EID: 0038054496     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00152-7     Document Type: Article

References (23)

1. Gate L., Tew K.D. Glutathione S-transferases as emerging therapeutic targets. Expert. Opin. Ther. Targets. 5:2001;477-489.
2. Cho S.G., Lee Y.H., Park H.S., Ryoo K., Kang K.W., Park J., Eom S.J., Kim M.J., Chang T.S., Choi S.Y., Shim J., Kim Y., Dong M.S., Lee M.J., Kim S.G., Ichijo H., Choi E.J. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J. Biol. Chem. 276:2001;12749-12755.
3. Adler V., Yin Z., Fuchs S.Y., Benezra M., Rosario L., Tew K.D., Pincus M.R., Sardana M., Henderson C.J., Wolf C.R., Davis R.J., Ronai Z. Regulation of JNK signaling by GSTp. EMBO J. 18:1999;1321-1334.
4. Wang T., Arifoglu P., Ronai Z., Tew K.D. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J. Biol. Chem. 276:2001;20999-21003.
5. 2-induced cell death via coordinated regulation of stress kinases. Cancer Res. 60:2000;4053-4057.
6. Morgan A.S., Ciaccio P.J., Tew K.D., Kauvar L.M. Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother. Pharmacol. 37:1996;363-370.
7. Ruscoe J.E., Rosario L.A., Wang T., Gate L., Arifoglu P., Wolf C.R., Henderson C.J., Ronai Z., Tew K.D. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTπ) influences cell proliferation pathways. J. Pharmacol. Exp. Ther. 298:2001;339-345.
8. Hazzalin C.A., Mahadevan L.C. MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 3:2002;30-40.
9. Danilenko M., Wang X., Studzinski G.P. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J. Natl. Cancer Inst. 93:2001;1224-1233.
10. Wang X., Studzinski G.P. Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells. J. Cell Biochem. 82:2001;68-77.
11. Slosberg E.D., Yao Y., Xing F., Ikui A., Jirousek M.R., Weinstein I.B. The protein kinase C β-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells. Mol. Carcinog. 27:2000;166-176.
12. kip1 in PMA-induced differentiation of HL60 cells. FEBS Lett. 472:2000;50-52.
13. O'Brien M.L., Vulevic B., Freer S., Boyd J., Shen H., Tew K.D. Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein. J. Pharmacol. Exp. Ther. 291:1999;1348-1355.
14. Shelly C., Petruzzelli L., Herrera R. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation. Cell Growth Differ. 11:2000;501-506.
15. Kip1 in the promyelocytic leukemia cell line HL60 accelerates its lineage-specific differentiation. Anticancer Res. 19:1999;4935-4945.
16. Hu X., Moscinski L.C., Valkov N.I., Fisher A.B., Hill B.J., Zuckerman K.S. Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line. Cell Growth Differ. 11:2000;191-200.
17. Fujiwara S., Watanabe T., Nagatsu T., Gohda J., Imoto M., Umezawa K. Enhancement or induction of neurite formation by a protein tyrosine phosphatase inhibitor, 3,4-dephostatin, in growth factor-treated PC12h cells. Biochem. Biophys. Res. Commun. 238:1997;213-217.
18. English J., Pearson G., Wilsbacher J., Swantek J., Karandikar M., Xu S., Cobb M.H. New insights into the control of MAP kinase pathways. Exp. Cell Res. 253:1999;255-270.
19. Zhou B., Wang Z.X., Zhao Y., Brautigan D.L., Zhang Z.Y. The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases. J. Biol. Chem. 277:2002;31818-31825.
20. Camps M., Nichols A., Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 14:2000;6-16.
21. Brunet A., Roux D., Lenormand P., Dowd S., Keyse S., Pouyssegur J. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18:1999;664-674.
22. MAPK cascade. J. Biol. Chem. 272:1997;1368-1376.
23. Seimiya H., Sawabe T., Toho M., Tsuruo T. Phorbol ester-resistant monoblastoid leukemia cells with a functional mitogen-activated protein kinase cascade but without responsive protein tyrosine phosphatases. Oncogene. 11:1995;2047-2054.